U.S. Markets open in 4 hrs 48 mins

Label Expansion to Boost Revenue Growth for Amarin’s Vascepa

Margaret Patrick
Label Expansion to Boost Revenue Growth for Amarin’s Vascepa

Amarin or Iovance Biotherapeutics: Which Is a Better Pick in May?(Continued from Prior Part)Label expansionOn March 28, Amarin (AMRN) issued a press release announcing the submission of an sNDA (supplemental new drug application) to the FDA seeking